Infectious Disease Doctors in Jbsa Ft Sam Houston, TX Accepting Medicare

6 Infectious Disease doctors found. Showing 1 - 6

Dr. David Alton Lindholm, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-5554

Dr. Jason T Lanning, D.O. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-5554    Fax: 210-916-5900

Matthew Geringer, D.O. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-5554    Fax: 210-916-5900

Dr. Todd Joseph Vento, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3551 Roger Brooke Dr, Infectious Disease, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-5554    Fax: 210-916-5900

Mary Bartlett Ford, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Infectious Disease, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-6017    Fax: 210-916-5900

Dr. Kevin Scott Akers, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 3698 Chambers Pass, Jbsa Ft Sam Houston, TX 78234 Phone: 210-539-4676

News Archive

Forteo to remain Decision Resources' proprietary clinical gold standard for treatment of osteoporosis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.

ETView Medical enters into patent license agreement for thoracic surgery devices

ETView Medical Ltd. announced today that it has entered into an exclusive license agreement for 2 US patents with James S. Simon, M.D., of Tiburon, California. The licensed patents are U.S. Pat. No. 7,052,456, entitled "Airway products having LEDs", and U.S. Pat. No. 6,189,533, entitled "Endotracheal Intubation Device".

Edwards Lifesciences' net sales increase 15% to $618.0M in Q4 2014

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.

Read more Medical News

› Verified 3 days ago